These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 32470498)
1. Mitochondria and immunity in chronic fatigue syndrome. Anderson G; Maes M Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109976. PubMed ID: 32470498 [TBL] [Abstract][Full Text] [Related]
2. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). König RS; Albrich WC; Kahlert CR; Bahr LS; Löber U; Vernazza P; Scheibenbogen C; Forslund SK Front Immunol; 2021; 12():628741. PubMed ID: 35046929 [TBL] [Abstract][Full Text] [Related]
3. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin. Maes M; Twisk FN; Kubera M; Ringel K J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
5. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis. Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962 [TBL] [Abstract][Full Text] [Related]
6. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation. Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637 [TBL] [Abstract][Full Text] [Related]
7. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study. Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852 [TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways. Morris G; Anderson G; Maes M Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535 [TBL] [Abstract][Full Text] [Related]
9. Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study. Seton KA; Defernez M; Telatin A; Tiwari SK; Savva GM; Hayhoe A; Noble A; de Carvalho-KoK ALS; James SA; Bansal A; Wileman T; Carding SR Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895005 [TBL] [Abstract][Full Text] [Related]
10. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192 [TBL] [Abstract][Full Text] [Related]
11. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS. Maes M; Twisk FN Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome. Maes M Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898 [TBL] [Abstract][Full Text] [Related]
13. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms. Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625 [TBL] [Abstract][Full Text] [Related]
14. Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review. Wang JH; Choi Y; Lee JS; Hwang SJ; Gu J; Son CG Eur J Med Res; 2024 Mar; 29(1):148. PubMed ID: 38429822 [TBL] [Abstract][Full Text] [Related]
15. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors. Wirth K; Scheibenbogen C Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028 [TBL] [Abstract][Full Text] [Related]
16. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease. Arron HE; Marsh BD; Kell DB; Khan MA; Jaeger BR; Pretorius E Front Immunol; 2024; 15():1386607. PubMed ID: 38887284 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers. Maes M; Bosmans E; Kubera M Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]